Janiszewska, Michalina

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell

Cancer Genomics and DiagnosticsCancer Cells and Metastasis

Cited by 1,009

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature

Protein Degradation and InhibitorsChromatin Remodeling and Cancer

Cited by 632

IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer

Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development

RNA Research and SplicingDevelopmental Biology and Gene Regulation

Cited by 324

The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing

Degrauwe, N., Schlumpf, T. B., Janiszewska, M., Martin, P., Cauderay, A., Provero, P., Riggi, N., Suvà, M.-L., Paro, R., & Stamenkovic, I. (2016) · Cell Reports

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 136

Structural insights into IMP2 dimerization and RNA binding

Zorc, S. A., Munoz-Tello, P., O’Leary, T., Yu, X., Karadi Giridhar, M. N., Hondros, A. D., Hansel-Harris, A., Forli, S., Griffin, P. R., Kojetin, D. J., et al. (2025) · Journal of Structural Biology

Protein Structure and DynamicsRNA Research and Splicing

Cited by 5

Structural insights into IMP2 dimerization and RNA binding

Zorc, S., Munoz-Tello, P., O'Leary, T., Yu, X., Nag, M., Hansel-Harris, A., Forli, S., Griffin, P. R., Kojetin, D. J., Roy, R. N., et al. (2024) · Journal of Structural Biology

Protein Structure and DynamicsRNA Research and Splicing

Cited by 5